FUJIFILM Irvine Scientific has officially rebranded as FUJIFILM Biosciences, signalling its broader focus across the life sciences market.

FUJIFILM Biosciences, a global leader in cell culture solutions, has officially changed its legal name from FUJIFILM Irvine Scientific, Inc. to FUJIFILM Biosciences Inc., effective January 1, 2026. The rebrand, first announced in June as part of the FUJIFILM Life Sciences Group restructuring, builds on the company’s 55-year history as a pioneer in cell culture media while signalling its expanded offering across the life sciences market.

The company continues to provide a comprehensive portfolio of products and services for scientists and researchers, including cell culture media, feeds, specialty chemicals and reagents, single-use technologies, and human-induced pluripotent stem cell capabilities. The company says its solutions support discovery, development, and commercialisation of life-changing treatments aimed at improving patient outcomes globally.

“All of us at FUJIFILM Biosciences take immense pride in being a people-focused company that empowers our colleagues to create an exceptional customer experience,” said Brandon Pence, president and chief operating officer. “We utilise our 55-year legacy of deep industry knowledge to collaboratively develop innovative solutions and technologies that are supplied from our global network of manufacturing facilities. With this approach and our ongoing investments, we look ahead to a strong future with our employees, customers, and partners around the world.”

The name change reflects FUJIFILM Biosciences’ wider strategy to provide end-to-end life sciences solutions, building on its expertise in cell culture while supporting researchers and companies at every stage of the product lifecycle.